![Anne Vivian-Scott](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anne Vivian-Scott
Chief Executive Officer at BKIN Technologies Ltd.
Profile
Anne Vivian-Scott is currently the President & Chief Executive Officer at BKIN Technologies Ltd.
She previously worked as the Vice President-Commercial Development at PARTEQ Innovations.
Ms. Vivian-Scott completed her undergraduate degree at The University of Waterloo.
Anne Vivian-Scott active positions
Companies | Position | Start |
---|---|---|
BKIN Technologies Ltd.
![]() BKIN Technologies Ltd. BiotechnologyHealth Technology BKIN Technologies Ltd. develops robotic technology for sensor motor neuroscience. It allows them to study, with exquisite precision, the sensory, motor and cognitive impact of a wide range of brain injuries and diseases, such as: stroke, cardiac arrest, transient ischemic attack, traumatic brain injury and Parkinson’s disease. The firm products are KINARMA exoskeleton, end point labs, dexterity-E and standard test. The company was founded by Stephen Scott and Ian Brown in 2004 and is headquartered in Kingston, Canada. | Chief Executive Officer | 2008-12-31 |
Former positions of Anne Vivian-Scott
Companies | Position | End |
---|---|---|
PARTEQ Innovations
![]() PARTEQ Innovations Investment ManagersFinance Founded in 1987 by Queen's University at Kingston, Ontario, PARTEQ Innovations is a venture capital firm. | Corporate Officer/Principal | - |
Training of Anne Vivian-Scott
The University of Waterloo | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
PARTEQ Innovations
![]() PARTEQ Innovations Investment ManagersFinance Founded in 1987 by Queen's University at Kingston, Ontario, PARTEQ Innovations is a venture capital firm. | Finance |
BKIN Technologies Ltd.
![]() BKIN Technologies Ltd. BiotechnologyHealth Technology BKIN Technologies Ltd. develops robotic technology for sensor motor neuroscience. It allows them to study, with exquisite precision, the sensory, motor and cognitive impact of a wide range of brain injuries and diseases, such as: stroke, cardiac arrest, transient ischemic attack, traumatic brain injury and Parkinson’s disease. The firm products are KINARMA exoskeleton, end point labs, dexterity-E and standard test. The company was founded by Stephen Scott and Ian Brown in 2004 and is headquartered in Kingston, Canada. | Health Technology |
- Stock Market
- Insiders
- Anne Vivian-Scott